Biotechnology Value Trading Fund OS LP, Director, 10% Owner at Olema Pharmaceuticals, Inc. (OLMA), bought 3,111,420 shares at $9.84 ($29.6M) on 2023-09-12, disclosed to the SEC on 2023-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.84 | 52,801 | $520K | 1.8% |
| 2 | $9.84 | 52,801 | $520K | 1.8% |
| 3 | $9.84 | 677,853 | $6.7M | 22.5% |
| 4 | $9.84 | 677,853 | $6.7M | 22.5% |
| 5 | $9.84 | 775,278 | $7.6M | 25.7% |
| 6 | $9.84 | 775,278 |
| $7.6M |
| 25.7% |
| 7 | $0.00 | 99,556 | $0 | 0.0% |
| Total | $9.53 avg | 3,111,420 | $29.6M | 100% |
| Filing → |
| RPTX | BUY | 2023-11-03 | $5.6M | — | Filing → |
| OLMA | BUY | 2022-06-14 | $1.6M | — | Filing → |
| KYMR | BUY | 2022-01-26 | $20.6M | — | Filing → |